CNVs analysis showed that 287 samples (including No. 7–12) were CNV-negative, while five patients with ovarian cancer (No. 1–5) and one patient (No. 6) with pancreatic cancer were identified to carry CNVs in BRCA1 or BRCA2 genes (Figure 2). This evidence concerns the gene BRCA2 and familial pancreatic carcinoma.